ArticleCell biology international2022

Leishmania amazonensis from distinct clinical forms/hosts has polymorphisms in Lipophosphoglycans, displays variations in immunomodulatory properties and, susceptibility to antileishmanial drugs.

Felipe D Rêgo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.